- Home
- AIXI vs SILO Comparison
AIXI vs SILO Comparison
Compare AIXI & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIXI | SILO |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Apparel |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIXI | SILO |
|---|---|---|
| Price | $0.23 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 637.5K | 109.1K |
| Earning Date | 04-24-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,877,458.00 | $72,102.00 |
| Revenue This Year | $26.84 | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.19 | $0.27 |
| 52 Week High | $5.49 | $1.57 |
Technical Indicators
Market Signals| Indicator | AIXI | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 40.03 |
| Support Level | $0.20 | $0.29 |
| Resistance Level | $0.28 | $0.33 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 70.45 | 31.28 |
Price Performance
Historical ComparisonAbout AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.